Canine Oncology Opportunities in Translational Medicine
Cancer is now the leading cause of death in pets. If we look at humans, statistically, cancer is one of the top causes of death in humans around the globe and there is a lot of medical literature and ongoing research on the development, treatment, and control of the disease. However, when it comes to cancer in animals, research and knowledge are limited and the disease is as common in pets as it is in humans, specifically in dogs. Nearly 30% of the cats and 50% of the dogs in the US are diagnosed with a type of cancer after crossing the age of ten. There is great opportunity here to solve a serious unmet medical need. Hosted by Elanco Animal Health, this presentation will provide a case study and example of how to realise the opportunities for canine oncology in animal health today.
Dottie Brown, Senior Research Advisor, Translational Comparative Medical Research, Elanco
Bruce Taillon, Senior Director, External Innovation, Elanco
Cheryl London, External Academic Partner, Elanco